1. Home
  2. ELTX vs FEIM Comparison

ELTX vs FEIM Comparison

Compare ELTX & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.92

Market Cap

63.3M

Sector

Health Care

ML Signal

N/A

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

N/A

Current Price

$85.97

Market Cap

722.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTX
FEIM
Founded
2011
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
722.9M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
ELTX
FEIM
Price
$1.92
$85.97
Analyst Decision
Buy
Buy
Analyst Count
4
2
Target Price
$13.67
★ $95.50
AVG Volume (30 Days)
★ 324.7K
309.7K
Earning Date
11-12-2026
09-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ 0.41
Revenue
$2,301,000.00
★ $63,227,000.00
Revenue This Year
N/A
$30.80
Revenue Next Year
N/A
$26.18
P/E Ratio
★ N/A
$205.98
Revenue Growth
N/A
★ N/A
52 Week Low
$1.71
$26.05
52 Week High
$16.00
$89.76

Technical Indicators

Market Signals
Indicator
ELTX
FEIM
Relative Strength Index (RSI) 23.58 60.34
Support Level $1.71 $48.49
Resistance Level $3.32 $89.68
Average True Range (ATR) 0.11 4.14
MACD 0.04 -0.04
Stochastic Oscillator 29.88 52.36

Price Performance

Historical Comparison
ELTX
FEIM

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance, and Electronic Warfare systems. Its technology is used for a wide range of space and non-space applications. The company has two segments FEI-NY, and FEI-Zyfer. Majority of revenue come from FEI-NY which provides precision time, frequency generation and synchronization products and subsystems that are found on-board satellites, in ground-based communication systems and imbedded in mobile platforms operated by the U.S. military.

Share on Social Networks: